Tesamorelin and HIV-Associated Lipodystrophy
To treat HIV-associated lipodystrophy, the FDA has authorized the use of the GHRH analog Tesamorelin. The growth hormone (GH) levels in Tesamorelin may increase lean body mass, strengthen bone, burn fat, and even boost immunological function. In the therapeutic environment, tesamorelin’s fat-burning characteristics are of the utmost importance. Tesamorelin is also being studied as a […]
